PCLO.V - PharmaCielo Ltd.

TSXV - TSXV Delayed Price. Currency in CAD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
Currency in USD. All numbers in thousands
Revenue2018-12-312017-12-312017-07-312016-07-31
Total Revenue----
Cost of Revenue36.64421.37753.9752.485
Gross Profit-36.644-21.377-53.97-52.485
Operating Expenses
Research Development----
Selling General and Administrative21,793.47711,844.7426,844.3835,033.334
Non Recurring----
Others5.02194.882113.3759.65
Total Operating Expenses23,892.42612,702.557,306.2695,130.326
Operating Income or Loss-23,892.426-12,702.55-7,306.269-5,130.326
Income from Continuing Operations
Total Other Income/Expenses Net-523.639-327.098-281.092-3,510.824
Earnings Before Interest and Taxes-23,892.426-12,702.55-7,306.269-5,130.326
Interest Expense----
Income Before Tax-24,416.065-13,029.648-7,587.361-8,641.15
Income Tax Expense9.804--0.166
Minority Interest----
Net Income From Continuing Ops-24,425.869-13,029.648-7,587.361-8,641.316
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-24,425.869-13,029.648-7,587.361-8,641.316
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-24,425.869-13,029.648-7,587.361-8,641.316